Abstract
Antimicrobial resistance threatens to compromise the treatment of bacterial infectious diseases. Strains resistant to most (if not all) antibiotics available have emerged. Gram-positive such representatives include strains of Methicillinresistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococci (VRE) and highly-resistant to penicillin Streptococcus pneumoniae. Although the phenomenon of antimicrobial drug resistance is expanding, limited number of new antibiotics has been successfully developed in the last few decades. Several novel antimicrobial agents, however, are currently in diverse phases of development and undergoing clinical trials. This review will summarize the main candidates for novel antibacterial agents active against Gram-positive multi-resistant pathogens along with the discussion of some patents relevant to the topic.
Keywords: Antimicrobials, multidrug resistance, methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, penicillin-resistant Streptococcus pneumoniae, clinical trial, Glycopeptide-related Derivatives, Oritavancin, Carbapenems, Fluorocyclines
Recent Patents on Anti-Infective Drug Discovery
Title:Novel Antimicrobial Agents Against Multi-drug-resistant Gram-positive Bacteria: An Overview
Volume: 7 Issue: 3
Author(s): Venetia Giannakaki and Spiros Miyakis
Affiliation:
Keywords: Antimicrobials, multidrug resistance, methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, penicillin-resistant Streptococcus pneumoniae, clinical trial, Glycopeptide-related Derivatives, Oritavancin, Carbapenems, Fluorocyclines
Abstract: Antimicrobial resistance threatens to compromise the treatment of bacterial infectious diseases. Strains resistant to most (if not all) antibiotics available have emerged. Gram-positive such representatives include strains of Methicillinresistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococci (VRE) and highly-resistant to penicillin Streptococcus pneumoniae. Although the phenomenon of antimicrobial drug resistance is expanding, limited number of new antibiotics has been successfully developed in the last few decades. Several novel antimicrobial agents, however, are currently in diverse phases of development and undergoing clinical trials. This review will summarize the main candidates for novel antibacterial agents active against Gram-positive multi-resistant pathogens along with the discussion of some patents relevant to the topic.
Export Options
About this article
Cite this article as:
Giannakaki Venetia and Miyakis Spiros, Novel Antimicrobial Agents Against Multi-drug-resistant Gram-positive Bacteria: An Overview, Recent Patents on Anti-Infective Drug Discovery 2012; 7 (3) . https://dx.doi.org/10.2174/157489112803521959
DOI https://dx.doi.org/10.2174/157489112803521959 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Comparative Time-Kill Study of Doxycycline, Tigecycline, Cefazolin and Vancomycin Against Several Clones of Staphylococcus aureus
Current Clinical Pharmacology The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis
Current Radiopharmaceuticals Reducing the Development of Antibiotic Resistance in Critical Care Units
Current Pharmaceutical Biotechnology The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology Acute Phase Treatment of Pulmonary Embolism
Current Vascular Pharmacology Management of Asymptomatic Severe Aortic Stenosis
Current Cardiology Reviews Current Status of Newer Antiinfectives
Recent Patents on Anti-Infective Drug Discovery Current Status of Carbapenem Antibiotics
Current Topics in Medicinal Chemistry Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI
Current Pharmaceutical Biotechnology Isolation of <i>Morganella Morganii</i> and <i>Providencia</i> Species from Clinical Samples in a Tertiary Care Hospital in North India
Infectious Disorders - Drug Targets Imidazole Derivatives and their Antibacterial Activity - A Mini-Review
Mini-Reviews in Medicinal Chemistry Preface
Recent Patents on Anti-Infective Drug Discovery Antimicrobial Peptides as Anti-biofilm Agents in Medical Implants
Current Topics in Medicinal Chemistry The Importance of Guidelines in the Development and Application of Probiotics
Current Pharmaceutical Design Infection and Hemodialysis Access: An Updated Review.
Infectious Disorders - Drug Targets Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1H-pyrazol-4- yl)methylene)-2-thioxothiazolidin-4-one Derivatives
Medicinal Chemistry Severe Community-Acquired Pneumonia (CAP) due to Atypical Pathogens
Current Respiratory Medicine Reviews Acethylcholinesterase Inhibition, Antibacterial and Antioxidant Properties of Diaryl Oxalates
Current Enzyme Inhibition Cardiovascular Complications of HIV Infection and Treatment
Cardiovascular & Hematological Agents in Medicinal Chemistry Radiolabeled Organism-Specific Antibodies for Diagnosis and Therapy of Infections
Current Medical Imaging